Identification of novel genetic markers of breast cancer survival.
Guo Q, Schmidt MK, Kraft P et al.
Publication Details
Comprehensive information about this research publication
Authors
Abstract
Summary of the research findings
Survival after a diagnosis of breast cancer varies considerably between patients, and some of this variation may be because of germline genetic variation. We aimed to identify genetic markers associated with breast cancer-specific survival.
23,059 European ancestry estrogen-receptor positive cases, 6,881 European ancestry estrogen-receptor negative cases, 8,014 European ancestry cases
Study Statistics
Key metrics and study information
AI-Generated Summary
AI-generated by DNAGENICSIndependent AI summary of health and genetic findings from the published study
Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.
AI Summary In Progress
Our AI-generated summary of this publication is being prepared. Please check back soon.
Summary
Key Findings
Health Insights
Disease Analysis
Genetic Trait Analysis
Clinical Relevance
Related Publications
Other publications that may be of interest
Genome-Wide Interaction Analysis of Genetic Variants with Menopausal Hormone Therapy for Colorectal Cancer Risk.
Tian Y
J Natl Cancer Inst
Colorectal cancer x menopausal hormone therapy interaction
Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.
Lindstrom S
J Natl Cancer Inst
Cancer (pleiotropy)
Genome-wide association study of susceptibility loci for TCF3-PBX1 acute lymphoblastic leukemia in children.
Lee SHR
J Natl Cancer Inst
Childhood acute lymphoblastic leukemia (TCF3-PBX1 fusion)
Different Pigmentation Risk Loci for High-Risk Monosomy 3 and Low-Risk Disomy 3 Uveal Melanomas.
Mobuchon L
J Natl Cancer Inst
Uveal melanoma
Association of GATA3 polymorphisms with minimal residual disease and relapse risk in childhood acute lymphoblastic leukemia.
Zhang H
J Natl Cancer Inst
End-of-induction therapy minimal residual disease in childhood acute lymphoblastic leukemia
Explore More Research
Discover the latest findings in health and genetic research